Llwytho...

Monitoring Molecular Response in Chronic Myeloid Leukemia

BACKGROUND: Prior to the advent of tyrosine kinase inhibitor (TKI) therapy, the evaluation of hematologic and cytogenetic responses was sufficient to gauge treatment efficacy in patients with chronic myeloid leukemia. However, with more potent TKI therapies, the majority of patients achieve complete...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer
Prif Awduron: Cortes, Jorge, Quintás-Cardama, Alfonso, Kantarjian, Hagop M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4969001/
https://ncbi.nlm.nih.gov/pubmed/20960522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25527
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!